CONCORD, NC - August 11, 2025 (NEWMEDIAWIRE) - Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, today announced certain preliminary, unaudited financial results for the quarter ended June 30, 2025. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2025 year-end financial reporting processes, reviews, audit, and potential adjustments, each of which could result in changes to the numbers reported.
For the quarter ended June 30, 2025, Hydromer generated revenue of $0.94 million, a 14% increase compared to $0.82 million in the second quarter of 2024. The Company reported a net loss of $38,000 in the second quarter due to legal and professional matters, and expenses associated with facility and equipment upgrades.
"This quarter reflects both the resilience of our core business and the deliberate steps we are taking to position Hydromer for sustainable, long-term growth. The increase in revenue year-over-year demonstrates the strength of our customer relationships and the value of our coating technologies in the medical device sector. While certain expenses impacted profitability, we view these as strategic investments that clear the path for accelerated innovation, market expansion, and stronger financial performance in the quarters ahead. Our focus remains on advancing our high-value product pipeline, forging new partnerships, and executing with discipline,” said Michael E.Torti, CEO of Hydromer.
Hydromer remains committed to building a scalable, innovation-driven platform and will continue to prioritize operational efficiency, customer partnerships, and next-generation technology development.
About Hydromer
Hydromer, Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for a wide variety of applications. We are domiciled in Concord, NC. Our customers are located across the United States, Europe and Asia-Pacific. Our facilities are compliant to, Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. We manage numerous global B2B services such as the sale of proprietary coating formulations, custom coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and hold patents worldwide.
Contact:
Hydromer Inc.
Info@hydromer.com
Forward-Looking Statements
This press release contains forward-looking statements that are based on Hydromer’s current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
